Cargando…

Correction to: Patients’ usability of seven most used dry-powder inhalers in COPD

Detalles Bibliográficos
Autores principales:	Dal Negro, Roberto W., Turco, Paola, Povero, Massimiliano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880364/ https://www.ncbi.nlm.nih.gov/pubmed/31788243 http://dx.doi.org/10.1186/s40248-019-0204-5

Ejemplares similares

Patients’ usability of seven most used dry-powder inhalers in COPD
por: Dal Negro, Roberto W., et al.
Publicado: (2019)

The Global Usability Score Short-Form for the simplified assessment of dry powder inhalers (DPIs) usability
por: Povero, Massimiliano, et al.
Publicado: (2020)

Dry-powder inhalers in patients with persistent airflow limitation: usability and preference
por: Dal Negro, Roberto W., et al.
Publicado: (2016)

A Bayesian Framework to Assess the Usability of Dry Powder Inhalers in a Cohort of Asthma Adolescents in Italy
por: Dal Negro, Roberto Walter, et al.
Publicado: (2021)

Lung Function Can Predict the Expected Inspiratory Airflow Rate through Dry Powder Inhalers in Asthmatic Adolescents
por: Dal Negro, Roberto Walter, et al.
Publicado: (2022)

Cultural and linguistic validation of the NHQ-2 Questionnaire: a specific instrument for assessing patient’s usability of inhalation devices
por: Dal Negro, Roberto W., et al.
Publicado: (2016)

Acceptability and preference of three inhalation devices assessed by the Handling Questionnaire in asthma and COPD patients
por: Dal Negro, Roberto W., et al.
Publicado: (2016)

Dry powder inhalers and the right things to remember: a concept review
por: Dal Negro, Roberto W
Publicado: (2015)

Cost of acute cough in Italian children
por: Negro, Roberto W Dal, et al.
Publicado: (2018)

The contribution of patients’ lung function to the inspiratory airflow rate achievable through a DPIs’ simulator reproducing different intrinsic resistance rates
por: Dal Negro, Roberto W., et al.
Publicado: (2021)

Comparison of Consistency, Feasibility, and Convenience of a Novel Compact System for Assessing Lung Volumes and Carbon Monoxide Diffusing Capacity versus Whole Body Plethysmography
por: Dal Negro, Roberto W, et al.
Publicado: (2021)

Nebivolol: an effective option against long-lasting dyspnoea following COVID-19 pneumonia - a pivotal double-blind, cross-over controlled study
por: Dal Negro, Roberto W., et al.
Publicado: (2022)

Long-lasting dyspnoea in patients otherwise clinically and radiologically recovered from COVID pneumonia: a probe for checking persisting disorders in capillary lung volume as a cause
por: Dal Negro, Roberto W., et al.
Publicado: (2022)

Inspiratory flow profile and usability of the NEXThaler, a multidose dry powder inhaler, in asthma and COPD
por: Chetta, Alfredo, et al.
Publicado: (2021)

Usability and Robustness of the Wixela Inhub Dry Powder Inhaler
por: Allan, Richard, et al.
Publicado: (2021)

The Emotional Response to Pandemic of Middle- and High-School Students of an Italian Northern Province: The ERP Study
por: Povero, Massimiliano, et al.
Publicado: (2022)

The economic impact of educational training assessed by the Handling Questionnaire with three inhalation devices in asthma and Chronic Obstructive Pulmonary Disease patients
por: Dal Negro, Roberto W, et al.
Publicado: (2016)

Influenza and influenza-like syndromes: the subjects’ beliefs, the attitude to prevention and treatment, and the impact in Italian general population
por: Dal Negro, Roberto W., et al.
Publicado: (2018)

Acute cough in Italian children: parents’ beliefs, approach to treatment, and the family impact
por: Dal Negro, Roberto W., et al.
Publicado: (2019)

Correction to: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma
por: Dal Negro, Roberto W., et al.
Publicado: (2018)

In vitro dose comparison of Respimat(®) inhaler with dry powder inhalers for COPD maintenance therapy
por: Ciciliani, Anna-Maria, et al.
Publicado: (2017)

The Extra Cost Due to Non-Adherence to Inhaled Treatments in Adolescents with Mild-to-Moderate Persistent Asthma
por: Dal Negro, Roberto Walter, et al.
Publicado: (2023)

Clinical recommendations for dry powder inhaler use in the management of COPD in primary care
por: Leving, Marika T., et al.
Publicado: (2022)

Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers
por: W. H. Kocks, Janwillem, et al.
Publicado: (2022)

Randomized dose-finding study of batefenterol via dry powder inhaler in patients with COPD
por: Crim, Courtney, et al.
Publicado: (2019)

Prevalence and clinical features of most frequent phenotypes in the Italian COPD population: the CLIMA Study
por: Dal Negro, Roberto W., et al.
Publicado: (2021)

Instant velocity and consistency of emitted cloud change by the different levels of canister filling with Metered Dose Inhalers (MDIs), but not with Soft Mist Inhalers (SMIs): a bench study
por: Dal Negro, Roberto W., et al.
Publicado: (2017)

Sensitivity of the COPD assessment test (CAT questionnaire) investigated in a population of 681 consecutive patients referring to a lung clinic: the first Italian specific study
por: Negro, Roberto W Dal, et al.
Publicado: (2014)

Delivery characteristics and patients’ handling of two single-dose dry-powder inhalers used in COPD
por: Chapman, Kenneth R, et al.
Publicado: (2011)

Costs of illness analysis in Italian patients with chronic obstructive pulmonary disease (COPD): an update
por: Dal Negro, Roberto W, et al.
Publicado: (2015)

Concept review of dry powder inhalers: correct interpretation of published data
por: Price, David, et al.
Publicado: (2015)

Budesonide–formoterol (inhalation powder) in the treatment of COPD
por: Ceylan, Erkan
Publicado: (2006)

Effect of Inhaler Design Variables on Paediatric Use of Dry Powder Inhalers
por: Lexmond, Anne J., et al.
Publicado: (2014)

Simultaneous Spray Drying for Combination Dry Powder Inhaler Formulations
por: Shepard, Kimberly B., et al.
Publicado: (2022)

Qualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPD
por: Svedsater, Henrik, et al.
Publicado: (2013)

Profile of fluticasone furoate/vilanterol dry powder inhaler combination therapy as a potential treatment for COPD
por: Caramori, Gaetano, et al.
Publicado: (2014)

Assessment of satisfaction with different dry powder inhalation devices in Greek patients with COPD and asthma: the ANASA study
por: Zervas, Eleftherios, et al.
Publicado: (2016)

Do Face-to-Face Training and Telephonic Reminder Improve Dry Powder Inhaler Technique in Patients with COPD?
por: Poudel, Ramesh Sharma, et al.
Publicado: (2017)

Ciprofloxacin dry powder inhaler in cystic fibrosis
por: Elborn, J Stuart
Publicado: (2016)

Understanding the Importance of Capsules in Dry Powder Inhalers
por: Buttini, Francesca, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ici1i2pjn4tlcljtcperpbp1af